Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Galloway

Showing results (381-390 of 421) with videos related to

Pageof 43
Sort By:
Journal of Clinical Hypertension (Greenwich, Conn.)|October 13, 2009
Safety and feasibility of achieving lower systolic blood pressure goals in persons with type 2 diabetes: the SANDS trialMatthew R Weir, Fawn Yeh, Angela Silverman, et al.
Regulatory Toxicology and Pharmacology : RTP|February 7, 2018
Potential impurities in drug substances: Compound-specific toxicology limits for 20 synthetic reagents and by-products, and a class-specific toxicology limit for alkyl bromidesJ P Bercu, S M Galloway, P Parris, et al.
ACS Nano|December 26, 2017
Bioinspired Silicification Reveals Structural Detail in Self-Assembled Peptide CagesJohanna M Galloway, Laura Senior, Jordan M Fletcher, et al.
Circulation|March 17, 2005
Discovering the full spectrum of cardiovascular disease: Minority Health Summit 2003: report of the Advocacy Writing GroupAntronette K Yancey, Robert G Robinson, Robert K Ross, et al.
Mutation Research|December 22, 2020
Corrigendum to "Bacterial mutagenicity screening in the pharmaceutical industry" [Mutat. Res. 752(2) (2013) 99-118]P A Escobar, R A Kemper, J Tarca, et al.
Mutation Research|December 25, 2012
Bacterial mutagenicity screening in the pharmaceutical industryP A Escobar, R A Kemper, J Tarca, et al.
Journal of Clinical Lipidology|June 22, 2010
Cost-effectiveness of lower targets for blood pressure and low-density lipoprotein cholesterol in diabetes: the Stop Atherosclerosis in Native Diabetics Study (SANDS) Charlton Wilson, Chun-Chih Huang, Nawar Shara, et al.
Neurobiology of Aging|January 4, 2011
Amyloid precursor protein (APP) processing genes and cerebrospinal fluid APP cleavage product levels in Alzheimer's diseaseL M Bekris, N M Galloway, S Millard, et al.
Environmental and Molecular Mutagenesis|July 24, 2019
In Vivo Mutagenicity Testing of Arylboronic Acids and EstersMelisa J Masuda-Herrera, Krista L Dobo, Michelle O Kenyon, et al.
Journal of Alzheimer'S Disease : JAD|April 24, 2008
Multiple SNPs within and surrounding the apolipoprotein E gene influence cerebrospinal fluid apolipoprotein E protein levelsLynn M Bekris, Steven P Millard, Nichole M Galloway, et al.
Pageof 43

Showing results (381-390 of 421) with videos related to

Sort By:
Pageof 43
Journal of Clinical Hypertension (Greenwich, Conn.)|October 13, 2009
Safety and feasibility of achieving lower systolic blood pressure goals in persons with type 2 diabetes: the SANDS trialMatthew R Weir, Fawn Yeh, Angela Silverman, et al.
Regulatory Toxicology and Pharmacology : RTP|February 7, 2018
Potential impurities in drug substances: Compound-specific toxicology limits for 20 synthetic reagents and by-products, and a class-specific toxicology limit for alkyl bromidesJ P Bercu, S M Galloway, P Parris, et al.
ACS Nano|December 26, 2017
Bioinspired Silicification Reveals Structural Detail in Self-Assembled Peptide CagesJohanna M Galloway, Laura Senior, Jordan M Fletcher, et al.
Circulation|March 17, 2005
Discovering the full spectrum of cardiovascular disease: Minority Health Summit 2003: report of the Advocacy Writing GroupAntronette K Yancey, Robert G Robinson, Robert K Ross, et al.
Mutation Research|December 22, 2020
Corrigendum to "Bacterial mutagenicity screening in the pharmaceutical industry" [Mutat. Res. 752(2) (2013) 99-118]P A Escobar, R A Kemper, J Tarca, et al.
Mutation Research|December 25, 2012
Bacterial mutagenicity screening in the pharmaceutical industryP A Escobar, R A Kemper, J Tarca, et al.
Journal of Clinical Lipidology|June 22, 2010
Cost-effectiveness of lower targets for blood pressure and low-density lipoprotein cholesterol in diabetes: the Stop Atherosclerosis in Native Diabetics Study (SANDS) Charlton Wilson, Chun-Chih Huang, Nawar Shara, et al.
Neurobiology of Aging|January 4, 2011
Amyloid precursor protein (APP) processing genes and cerebrospinal fluid APP cleavage product levels in Alzheimer's diseaseL M Bekris, N M Galloway, S Millard, et al.
Environmental and Molecular Mutagenesis|July 24, 2019
In Vivo Mutagenicity Testing of Arylboronic Acids and EstersMelisa J Masuda-Herrera, Krista L Dobo, Michelle O Kenyon, et al.
Journal of Alzheimer'S Disease : JAD|April 24, 2008
Multiple SNPs within and surrounding the apolipoprotein E gene influence cerebrospinal fluid apolipoprotein E protein levelsLynn M Bekris, Steven P Millard, Nichole M Galloway, et al.
Pageof 43